CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 401 enrolled
Drug / intervention
TV Annuloplasty +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02675244
NCT02675244N/ACompleted

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

Icahn School of Medicine at Mount Sinai·interventional·Posted Feb 5, 2016·Updated Jun 18, 2024

In Brief

A clinical study evaluating TV Annuloplasty and MVS for Mild Tricuspid Regurgitation and 2 related conditions. Completed, enrolled 401 participants across 41 sites in 3 countries.

Detailed Summary

The purpose of the research is to determine whether repairing a tricuspid valve (TV) in patients with mild to moderate tricuspid regurgitation (TR), at the time of planned mitral valve surgery (MVS), would improve the heart health of those who receive it compared to those who do not. At this point, the medical community is split in their opinion on whether surgeons should routinely repair mild to moderate TR in patients who are undergoing planned mitral valve surgery, and this study will answer this question.

Study Details

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 5, 2016
Enrollment StartMay 26, 2016
Primary CompletionApr 19, 2021
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 10.4 years ago

Interventions

TV Annuloplastyprocedure

TV Annuloplasty will be performed using standard surgical techniques

MVSprocedure

MVS will be performed using standard surgical techniques